Vistance Networks (VISN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
The annual meeting is scheduled for May 7, 2026, and will be held virtually, with voting rights extended to shareholders of record as of March 11, 2026.
Key proposals include election of eight directors, advisory votes on executive compensation and its frequency, approval of additional shares under the 2019 Long-Term Incentive Plan, and ratification of Ernst & Young LLP as auditor.
The company experienced significant transformation in 2025, including divestitures, strong financial performance, and a 248% increase in stock price.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eight directors, (2) advisory approval of executive compensation, (3) frequency of future say-on-pay votes, (4) approval of additional shares for the 2019 Long-Term Incentive Plan, and (5) ratification of Ernst & Young LLP as auditor.
The board recommends voting FOR all proposals and EVERY YEAR for the frequency of say-on-pay votes.
Shareholder proposals for the 2027 meeting must be submitted by November 23, 2026.
Board of directors and corporate governance
The board consists of eight members, with a mix of independent and non-independent directors, and includes a Lead Independent Director.
Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined responsibilities and independent membership.
Annual board and committee self-evaluations are conducted, and all directors attended at least 80% of meetings in 2025.
Stock ownership guidelines require directors to hold significant equity, aligning interests with shareholders.
Latest events from Vistance Networks
- Director elections, executive pay, auditor ratification, and incentive plan shares up for vote.VISN
Proxy filing23 Mar 2026 - Core adjusted EBITDA up 176% in 2025; $10/share special distribution planned.VISN
Q4 202526 Feb 2026 - Adjusted EBITDA up nearly 20% as CCS growth offsets declines; $2.1B OWN/DAS sale to aid liquidity.VISN
Q2 20242 Feb 2026 - Core adjusted EBITDA rose 25% on strong CCS gains; OWN and DAS divestiture set for Q1 2025.VISN
Q3 202416 Jan 2026 - Core adjusted EBITDA up 159% on 23.5% sales growth; 2025 guidance reaffirmed.VISN
Q1 202524 Dec 2025 - Q4 core sales jumped 27% and margins rose, with 2025 EBITDA guidance at $1.00–$1.05B.VISN
Q4 202421 Dec 2025 - Definitive agreement to sell CCS segment to Amphenol, pending shareholder approval and regulatory review.VISN
Proxy Filing2 Dec 2025 - CCS business sale unlocks equity, enables debt repayment, and sets up a major shareholder dividend.VISN
Proxy Filing1 Dec 2025 - $10.5B sale of CCS segment to Amphenol, pending approvals and board support.VISN
Proxy Filing1 Dec 2025